Filing Flows › Procept BioRobotics (PRCT) › Q4 2025
Procept BioRobotics (PRCT) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Feb 26, 2026
Procept BioRobotics (PRCT) reported revenue of $76.4M for the fourth quarter 2025 (Q4 2025), +12% from a year earlier and -8% from the quarter before. Operating margin was -40.6%, net loss $29.8M (39.1% of revenue).
Procept BioRobotics, Q4 2025: revenue $76.4M (+12% year over year), operating margin -40.6%, net loss $29.8M, operating cash flow −$10.3M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $76.4M | -8% | +12% |
| Operating profit | −$31.0M | — | — |
| Net earnings | −$29.8M | — | — |
| Operating cash flow | −$10.3M | — | — |
What changed
Revenue was $76.4M in Q4 2025, up 12% year over year and down 8% from the previous quarter.
Gross margin was 60.6%, down 3.4 points from a year earlier. Operating costs exceeded revenue by $31.0M, an operating margin of -40.6%. Operating expenses grew 22% against revenue growth of 12%. The fastest-growing cost line was Research & development (+26%). The quarter ended with a net loss of $29.8M, wider than the previous quarter's $21.4M loss.
Operating cash flow was −$10.3M. Non-cash charges added back $1.7M of depreciation and amortization and $10.8M of share-based compensation. Working capital and other items added $7.0M. Capital expenditures of $1.9M exceeded it, leaving free cash flow of −$12.2M.
Questions
What was Procept BioRobotics' revenue in the fourth quarter 2025?
Procept BioRobotics (PRCT) reported revenue of $76.4M for the fourth quarter 2025 (Q4 2025), +12% from a year earlier and -8% from the quarter before.
Was Procept BioRobotics profitable in the fourth quarter 2025?
Operating loss was $31.0M (-40.6% of revenue) and net loss $29.8M.